Capricor Therapeutics Inc (NAS:CAPR)
$ 17.09 0.55 (3.33%) Market Cap: 603.92 Mil Enterprise Value: 556.15 Mil PE Ratio: 0 PB Ratio: 47.42 GF Score: 71/100

Q4 2023 Capricor Therapeutics Inc Earnings Call Transcript

Feb 29, 2024 / 09:30PM GMT
Release Date Price: $4.2 (-3.00%)
Operator

Good afternoon, ladies and gentlemen, and welcome to Capricor Therapeutics' fourth-quarter 2023 earnings call. (Operator Instructions)

This call is being recorded on Thursday, February 29, 2024.

I would now like to turn the conference over to AJ Bergmann, CFO of Capricor. Please go ahead.

Anthony Bergmann
Capricor Therapeutics Inc - Chief Financial Officer

Thank you, and thank you for joining today. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy safety and intended utilization of our product candidates; our future R&D plans, including our anticipated conduct and timing of preclinical and clinical studies; our enrollment of patients in our clinical studies; our plans to present or report additional data; our plans regarding regulatory filings, potential regulatory developments involving our product candidates; manufacturing capabilities; potential milestone payments; our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot